5-Hexynoic acid, 3-amino-, (3S)-


Chemical Name: 5-Hexynoic acid, 3-amino-, (3S)-
CAS Number: 270596-46-8
Product Number: AG00BEX0(AGN-PC-0O8H9D)
Synonyms:
MDL No:
Molecular Formula: C6H9NO2
Molecular Weight: 127.14116

Identification/Properties


Computed Properties
Molecular Weight:
163.601g/mol
Hydrogen Bond Donor Count:
3
Hydrogen Bond Acceptor Count:
3
Rotatable Bond Count:
3
Exact Mass:
163.04g/mol
Monoisotopic Mass:
163.04g/mol
Topological Polar Surface Area:
63.3A^2
Heavy Atom Count:
10
Formal Charge:
0
Complexity:
144
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
1
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
2
Compound Is Canonicalized:
Yes

Safety Information


GHS Pictogram:
N/A
Signal Word:
UN#:
-
Hazard Statements:
-
Precautionary Statements:
Class:
-
Packing Group:
-

NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



H-β-HoGly(Propargyl)-OH is a versatile chemical reagent commonly used in organic synthesis. Its primary application lies in the field of peptide chemistry, where it serves as a valuable building block for the synthesis of peptides and proteins. Due to its unique structure, H-β-HoGly(Propargyl)-OH provides a reactive propargyl functional group that can participate in various types of chemical reactions, including click chemistry reactions and peptide bond formations. This reactivity allows chemists to introduce specific modifications or functionalities into peptide sequences, thereby enabling the design and creation of novel peptide structures with tailored properties.Furthermore, H-β-HoGly(Propargyl)-OH's compatibility with solid-phase peptide synthesis (SPPS) techniques makes it a particularly useful tool for the efficient assembly of peptide chains. By incorporating this reagent at strategic positions within a peptide sequence, chemists can achieve site-selective modifications or conjugations, enhancing the versatility and applicability of the synthesized peptides for various research or therapeutic purposes.